Enrique Schisterman, PhD,of NICH and his colleagues ran trials on 1,228 healthy women and found interesting results: with only one miscarriage at less than 20 weeks in the previous year, these women were 9.2% more likely to have a live birth if they consumed aspirin daily.

Schisterman explains during a meeting in San Francisco that aspirin reduces inflammation and improves blood flow to the uterus among other key structures.

The institute is still waiting for official confirmation from a future trial that this can be a remedy. Previous tests have had women use aspirin during conception but not preconception.

While women who had more than one miscarriage were immune from the effects of the aspirin, NICH is hoping to continue their research to identify whether there are even more effects of aspirin in the gestation and reproduction periods.